Skip to main content
Premium Trial:

Request an Annual Quote

Moving Past the Pandemic

President Biden's chief medical advisor Anthony Fauci said this week that the US has moved out of the pandemic phase of COVID-19 and into a "controlled phase," NPR reported on Wednesday. While SARS-CoV-2 continues to infect people across the globe, the high number of people who have been vaccinated and/or infected with the virus means that "you have a rather substantial proportion of the United States population that has some degree of immunity that's residual," Fauci is quoted as saying. Additionally, the availability of COVID-19 treatments such as Pfizer's Paxlovid antiviral pill "means you can come into a place, get tested and, if you are tested, immediately get put on therapy, if they're eligible."

Still, the pandemic is not over in other parts of the world and intermittent vaccination will be key to keeping the virus at bay in the US the long term, he said. "We're not going to eradicate this virus."

Fauci had to clarify his comments after saying on PBS Newshour on Tuesday that the US was "out of the pandemic phase."

He further told the Associated Press that there is more work to do, calling for more vaccinations and booster shots, as well as better access to treatments.

 

 

 

 

 

Filed under

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.